ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $521 | -22.8% | 14,623 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $675 | -4.5% | 14,623 | -17.0% | 0.00% | 0.0% |
| Q1 2023 | $707 | +24.9% | 17,623 | +44.2% | 0.00% | 0.0% |
| Q4 2022 | $566 | -99.9% | 12,223 | +16.2% | 0.00% | +33.3% |
| Q3 2022 | $436,000 | -30.6% | 10,523 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $628,000 | -17.8% | 10,523 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $764,000 | -13.7% | 10,523 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $885,000 | -6.7% | 10,523 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $949,000 | -5.4% | 10,523 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,003,000 | -20.8% | 10,523 | -5.4% | 0.01% | -28.6% |
| Q1 2021 | $1,266,000 | -8.7% | 11,123 | +11.0% | 0.01% | -12.5% |
| Q4 2020 | $1,387,000 | +68.3% | 10,023 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $824,000 | -38.9% | 10,023 | -41.9% | 0.01% | 0.0% |
| Q2 2020 | $1,348,000 | +137.3% | 17,246 | +115.6% | 0.01% | -64.7% |
| Q3 2016 | $568,000 | +45.3% | 8,000 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $391,000 | -22.7% | 8,000 | 0.0% | 0.02% | -27.3% |
| Q1 2016 | $506,000 | -71.8% | 8,000 | -50.0% | 0.02% | -37.1% |
| Q4 2015 | $1,795,000 | – | 16,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |